Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HTO: Smoking Cessation Treatments for Smokers With HIV
NCT04176172Phase 3Active, not recruiting
- Sponsor
- Abramson Cancer Center
- Start
- Feb 2020
- Primary completion
- Nov 2026
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of varenicline, nicotine patch in nicotine dependence, sponsored by Abramson Cancer Center. Started Feb 2020; status: active, not recruiting.
02
Drugs
vareniclinenicotine patch
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT04176172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04176172.